CIK 0001520262
- Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981007018
- Phone
- +353 17728000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $697,937
- in 4 filings, $698K under 10b5-1 plans
Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-21 | Brown Iain Michael SVP, Chief Financial Officer | Shares withheld for taxes | −1,412 | $19.58 | $28K | 48,362 |
| 2021-02-21 | Brown Iain Michael SVP, Chief Financial Officer | Exercise or conversion · Restricted Stock Unit Award | −4,800 | 9,600 | ||
| 2021-02-20 | Nichols Christian Todd SVP, Chief Commercial Officer | Exercise or conversion | +3,824 | 6,295 | ||
| 2021-02-20 | Nichols Christian Todd SVP, Chief Commercial Officer | Shares withheld for taxes | −1,292 | $19.58 | $25K | 5,003 |
| 2021-02-20 | Nichols Christian Todd SVP, Chief Commercial Officer | Exercise or conversion · Restricted Stock Unit Award | −3,824 | 11,473 | ||
| 2021-02-20 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Exercise or conversion | +5,353 | 215,903 | ||
| 2021-02-20 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Shares withheld for taxes | −2,360 | $19.58 | $46K | 213,543 |
| 2021-02-20 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Exercise or conversion | +5,825 | 219,368 | ||
| 2021-02-20 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Exercise or conversion · Restricted Stock Unit Award | −5,353 | 16,062 | ||
| 2021-02-20 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Exercise or conversion · Restricted Stock Unit Award | −5,825 | 11,650 | ||
| 2021-02-20 | Jackson Blair Curtis EVP, Chief Operating Officer | Exercise or conversion | +4,589 | 66,140 | ||
| 2021-02-20 | Jackson Blair Curtis EVP, Chief Operating Officer | Shares withheld for taxes | −1,374 | $19.58 | $27K | 64,766 |
| 2021-02-20 | Jackson Blair Curtis EVP, Chief Operating Officer | Exercise or conversion · Restricted Stock Unit Award | −4,589 | 13,767 | ||
| 2021-02-20 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Exercise or conversion | +10,095 | 27,131 | ||
| 2021-02-20 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Shares withheld for taxes | −3,064 | $19.58 | $60K | 24,067 |
| 2021-02-20 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Exercise or conversion · Restricted Stock Unit Award | −10,095 | 30,287 | ||
| 2021-02-20 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Exercise or conversion | +7,036 | 71,805 | ||
| 2021-02-20 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −2,061 | $19.58 | $40K | 69,744 |
| 2021-02-20 | Gaffin David Joseph SVP, CLO, Alkermes, Inc. | Exercise or conversion · Restricted Stock Unit Award | −7,036 | 21,109 | ||
| 2021-02-20 | Brown Iain Michael SVP, Chief Financial Officer | Exercise or conversion | +4,589 | 46,352 |
Page 67 of 75 · 1,492 trades